More recently, PGE2 has also been identified as a tumor-induced immunosuppressive factor, able to mediate the reprogramming of the tumor microenvironment [19], or as a direct modulator of macrophage activity by transactivation of CSF-1R [20]. The gene discussed is CSF1R; the disease is neoplasm.